Kenichi Nishioji

1.9k total citations
26 papers, 1.5k citations indexed

About

Kenichi Nishioji is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Kenichi Nishioji has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Kenichi Nishioji's work include Hepatitis C virus research (9 papers), Systemic Lupus Erythematosus Research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Kenichi Nishioji is often cited by papers focused on Hepatitis C virus research (9 papers), Systemic Lupus Erythematosus Research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Kenichi Nishioji collaborates with scholars based in Japan, Poland and Greece. Kenichi Nishioji's co-authors include Yoshito Itoh, Takeshi Okanoue, Masafumi Sakamoto, Kei Kashima, Masahito Minami, Shosaku Narumi, Masao Kobayashi, Mai Kamaguchi, Yoshiki Murakami and Shinichi Sakamoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kenichi Nishioji

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenichi Nishioji Japan	17	820	778	284	250	218	26	1.5k
Fusao Ikeda Japan	26	1.5k 1.8×	1.3k 1.7×	201 0.7×	461 1.8×	190 0.9×	115	2.3k
Seigo Abiru Japan	22	866 1.1×	965 1.2×	142 0.5×	167 0.7×	129 0.6×	52	1.5k
Tetsuya Ichijo Japan	22	1.1k 1.4×	1.1k 1.5×	248 0.9×	109 0.4×	115 0.5×	45	1.6k
Philippe Podevin France	20	788 1.0×	1.2k 1.5×	130 0.5×	245 1.0×	344 1.6×	48	1.9k
M.F. Bassendine United Kingdom	24	928 1.1×	1.0k 1.3×	137 0.5×	122 0.5×	198 0.9×	67	1.7k
Ludger Leifeld Germany	26	824 1.0×	810 1.0×	143 0.5×	528 2.1×	220 1.0×	73	2.1k
Thomas Lang Germany	18	685 0.8×	737 0.9×	157 0.6×	217 0.9×	105 0.5×	42	1.5k
Claudia Shorthouse Australia	6	868 1.1×	924 1.2×	123 0.4×	219 0.9×	63 0.3×	7	1.3k
R. N. M. MacSween United Kingdom	24	686 0.8×	707 0.9×	175 0.6×	188 0.8×	179 0.8×	82	1.7k
N Abuaf France	21	1.1k 1.3×	974 1.3×	639 2.3×	311 1.2×	101 0.5×	85	2.2k

Countries citing papers authored by Kenichi Nishioji

Since Specialization

Citations

This map shows the geographic impact of Kenichi Nishioji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Nishioji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Nishioji more than expected).

Fields of papers citing papers by Kenichi Nishioji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Nishioji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Nishioji. The network helps show where Kenichi Nishioji may publish in the future.

Co-authorship network of co-authors of Kenichi Nishioji

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Nishioji. A scholar is included among the top collaborators of Kenichi Nishioji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Nishioji. Kenichi Nishioji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujiwara, Koichi, Kenichi Nishioji, Masao Kobayashi, et al.. (2022). Medical checkup data analysis method based on LiNGAM and its application to nonalcoholic fatty liver disease. Artificial Intelligence in Medicine. 128. 102310–102310. 8 indexed citations

Fujiwara, Koichi, Yukun Huang, Kenichi Nishioji, et al.. (2020). Over- and Under-sampling Approach for Extremely Imbalanced and Small Minority Data Problem in Health Record Analysis. Frontiers in Public Health. 8. 178–178. 58 indexed citations

Seko, Yuya, Kanji Yamaguchi, Naoki Mizuno, et al.. (2017). Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. Journal of Gastroenterology. 53(3). 438–448. 21 indexed citations

Nishioji, Kenichi, Masao Kobayashi, Mai Kamaguchi, et al.. (2015). The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals. PLoS ONE. 10(10). e0140427–e0140427. 64 indexed citations

Kobayashi, Masao, et al.. (2014). Usefulness and issues in gastric cancer risk assessment during medical checkups using the ABC classification system. Gastric Cancer. 52(5). 545–555. 1 indexed citations

Nishioji, Kenichi, Yoshio Sumida, Mai Kamaguchi, et al.. (2014). Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012. Journal of Gastroenterology. 50(1). 95–108. 122 indexed citations

Shindo, Michiko, et al.. (2004). The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B. Journal of Gastroenterology. 39(3). 260–267. 13 indexed citations

Morita, Atsuhiro, Kenichi Nishioji, Shosaku Narumi, et al.. (2001). Clinical significance of elevated serum interferon‐ inducible protein‐10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. Journal of Viral Hepatitis. 8(5). 341–348. 45 indexed citations

Narumi, Shosaku, Hiroyuki Yoneyama, Hidekuni Inadera, et al.. (2000). TNF-α IS A POTENT INDUCER FOR IFN-INDUCIBLE PROTEIN-10 IN HEPATOCYTES AND UNAFFECTED BY GM-CSF IN VIVO, IN CONTRAST TO IL-1β AND IFN-γ. Cytokine. 12(7). 1007–1016. 40 indexed citations

10.

Tamaru, Masahiro, Kenichi Nishioji, Yuko Kobayashi, et al.. (2000). LIVER-INFILTRATING T LYMPHOCYTES ARE ATTRACTED SELECTIVELY BY IFN-INDUCIBLE PROTEIN-10. Cytokine. 12(4). 299–308. 63 indexed citations

11.

Itoh, Yoshito, Takeshi Okanoue, Naoki Ohnishi, et al.. (1999). Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor. Liver International. 19(2). 97–103. 21 indexed citations

12.

Nishioji, Kenichi, et al.. (1999). Experimental Liver Injury Induced by Propionibacterium acnes and Lipopolysaccharide in Macrophage Colony Stimulating Factor-Deficient Osteopetrotic (op/op) Mice. Digestive Diseases and Sciences. 44(10). 1975–1984. 11 indexed citations

13.

Okanoue, Takeshi, Masahito Minami, Shinichi Sakamoto, et al.. (1999). Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Journal of Hepatology. 30(4). 653–659. 183 indexed citations

14.

Itoh, Yoshito, Takeshi Okanoue, Naoki Ohnishi, et al.. (1999). Serum Levels of Soluble Tumor Necrosis Factor Receptors and Effects of Interferon Therapy in Patients With Chronic Hepatitis C Virus Infection. The American Journal of Gastroenterology. 94(5). 1332–1340. 58 indexed citations

15.

Yasui, Kohichiroh, Takeshi Okanoue, Yoshiki Murakami, et al.. (1998). Dynamics of Hepatitis C Viremia following Interferon‐α Administration. The Journal of Infectious Diseases. 177(6). 1475–1479. 55 indexed citations

16.

Itoh, Yoshito, Takeshi Okanoue, Shinichi Sakamoto, Kenichi Nishioji, & Kei Kashima. (1997). The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B. Journal of Hepatology. 26(2). 244–252. 17 indexed citations

17.

Narumi, Shosaku, et al.. (1997). Expression of IFN-inducible protein-10 in chronic hepatitis. The Journal of Immunology. 158(11). 5536–5544. 145 indexed citations

18.

Okanoue, T, Yoshito Itoh, Masahito Minami, et al.. (1996). Side effects of high-dose interferon therapy for chronic hepatitis C. Journal of Hepatology. 25(3). 283–291. 329 indexed citations

19.

Itoh, Yoshito, Shinichi Sakamoto, Kenichi Nishioji, et al.. (1995). Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon. Digestive Diseases and Sciences. 40(11). 2423–2430. 9 indexed citations

20.

Nishioji, Kenichi, et al.. (1994). [A case of drug-induced hepatitis caused by Oriental herb-drug sai-rei-to].. PubMed. 91(10). 2016–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact